Y-Cort 6 Tablet contains Deflazacort 6 mg, a synthetic glucocorticoid used for its potent anti-inflammatory and immunosuppressive properties. It is indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort acts by modulating the immune response and reducing inflammation through inhibition of multiple inflammatory mediators. Y-Cort 6 is also employed in the treatment of certain muscular dystrophies to improve muscle strength and function. The medication should be administered under medical supervision, with dosage tailored to the severity of the condition and patient response. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, hyperglycemia, and potential adrenal suppression with prolonged use. Caution is advised in patients with diabetes, hypertension, osteoporosis, or peptic ulcer disease. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; gradual tapering is recommended when discontinuing therapy. Y-Cort 6 is contraindicated in systemic fungal infections and hypersensitivity to Deflazacort or any excipients. Regular monitoring of blood pressure, blood glucose, and electrolyte levels is essential during treatment. This medication should be used with caution during pregnancy and lactation, only if the potential benefits outweigh the risks.